ProShares Ultra Health Care (RXL) Price & Chart
RXL ETF Chart & Stats
- Day’s Range
- $70.06 - $71.45
- 52-Week Range
- $42.76 - $71.45
- Previous Close
- $69.45
- Volume
- 35.85K
- Average Volume (3M)
- 13.57K
- AUM
- 106.63M
- NAV
- 69.52
- Expense Ratio
- 0.95%
- Holdings Count
- 62
- Beta
- 0.74
- Inception Date
- Jan 30, 2007
- Last Dividend Ex-Date
- Sep 23, 2026
- Dividend Yield
- (0.90%)
- Shares Outstanding
- 1,610,000
- Standard Deviation
- N/A
ETF Overview
ProShares Ultra Health Care
ProShares Ultra Health Care (RXL) is an exchange-traded fund meticulously designed for those looking to capitalize on the dynamic opportunities within the health care sector. As a sector-focused ETF, RXL stands out by offering investors amplified exposure to the robust and ever-evolving health care industry. This fund seeks to provide twice the daily performance of the Dow Jones U.S. Health Care Index, allowing investors to leverage their investments to potentially achieve higher returns. In a broad-based niche, ProShares Ultra Health Care covers a comprehensive range of health care sub-sectors, including pharmaceuticals, biotechnology, medical devices, and health care providers. This diversified yet concentrated approach makes RXL an attractive option for investors aiming to harness the growth potential from innovations and advancements in medical technology and health care services. Whether you're looking to hedge existing health care positions or seeking a tactical investment to capitalize on short-term movements within the sector, RXL offers a compelling and efficient solution. With its focus on delivering leveraged exposure to health care, this ETF is tailored for investors with a strong conviction in the sector's growth trajectory and a higher risk tolerance.